KNSA - Kiniksa Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KNSA is currently covered by 4 analysts with an average price target of $47.91. This is a potential upside of $14.7 (44.26%) from yesterday's end of day stock price of $33.21.

Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 51 price targets and 43 ratings on display. The stock rating distribution of KNSA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.5% with an average time for these price targets to be met of 837.6 days.

Highest price target for KNSA is $40, Lowest price target is $34, average price target is $37.25.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 16-Apr-2025. First documented stock forecast 18-Jun-2018.

Best performing analysts who are covering KNSA - Kiniksa Pharmaceuticals Ltd:

Geoff Meacham Paul Choi David Nierengarten Liisa Bayko Anupam Rama

Currently out of the existing stock ratings of KNSA, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$34

$0.62 (1.86%)

$34

4 months 4 days ago
(16-Apr-2025)

7/10 (70%)

$13.46 (65.53%)

1016

Buy

$40

$6.62 (19.83%)

$28

5 months 7 days ago
(13-Mar-2025)

3/6 (50%)

$17.84 (80.51%)

585

Buy

$40

$6.62 (19.83%)

$39

9 months 15 days ago
(05-Nov-2024)

6/10 (60%)

$17.97 (81.57%)

348

Buy

$35

$1.62 (4.85%)

$30

9 months 22 days ago
(29-Oct-2024)

5/8 (62.5%)

$11.73 (50.41%)

1142

Buy

$32

$-1.38 (-4.13%)

$24

2 years 26 days ago
(25-Jul-2023)

6/8 (75%)

$12.52 (64.27%)

1097

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 837.6 days on average for the stock forecasts to be realized with a an average price target met ratio 63.5

Which analyst has the current highest performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?

Geoff Meacham works at BAML and has 12 price targets and 9 ratings on KNSA

Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?

Anupam Rama with highest potential upside - $6.62

Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?

Paul Choi with lowest potential downside - -$1.38

Kiniksa Pharmaceuticals Ltd in the News

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation

Growth investing often focuses on companies with strong revenue and earnings increases, but prices can rise quickly in popular stocks. The “Affordable Growth” strategy balances these factors by finding stocks with good growth potential that still trade at fair prices, backed by strong profitability and financial stability. This method helps investors avoid paying too much...

Just The Tonic: This Medical Stock, A Mutual Fund Darling, Tests Entry Amid 58% Run

A good medical stock can help diversify a portfolio. This particular name is testing a fresh entry as funds pile in. Earnings are seen taking off in the year ahead. Continue Reading View Comments
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?